(Q35791725)

10 August 2017

Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. (English)

1 reference

10 August 2017

1 reference

Sheila Chuang-Tsai

1

1 reference

10 August 2017

Thomas H Sisson

2

1 reference

10 August 2017

Noboru Hattori

3

1 reference

10 August 2017

Christopher G Tsai

4

1 reference

10 August 2017

Natalya M Subbotina

5

1 reference

10 August 2017

Kerstin E Hanson

6

1 reference

10 August 2017

Richard H Simon

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

The American Journal of Pathology

10 August 2017

1 reference

10 August 2017

163

1 reference

10 August 2017

2

1 reference

10 August 2017

445-452

1 reference

describes a project that uses

10 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC1868204/fullTextXML

inferred from PubMed Central ID database lookup

cites work

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

The urokinase receptor. A cell surface, regulated chemokine.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Exacerbation of antigen-induced arthritis in urokinase-deficient mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Biology and biochemistry of proteinases in tumor invasion.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

The urokinase receptor is required for human monocyte chemotaxis in vitro

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Alterations of and tissue reaction to polyvinyl alcohol sponge implants

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

The pathogenesis of bleomycin-induced pulmonary fibrosis in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Matrix metalloproteinases and their inhibitors in connective tissue remodeling

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Wound-healing defects in mice lacking fibrinogen

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868204

Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction

15 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963674-7

Plastic sponge which acts as a framework for living tissue; experimental studies and preliminary report of use to reinforce abdominal aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963674-7

A subcutaneous implant for wound healing studies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963674-7

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963674-7

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963674-7

Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963674-7

Connective tissue; a technique for its isolation and study

7 January 2021

1 reference

12 December 2020

Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes

1 reference

12 December 2020

Polymerization of fibrinogen in murine bleomycin-induced lung injury

1 reference

12 December 2020

Characterization of latent TGF-beta activation by murine peritoneal macrophages

1 reference

12 December 2020

10.1016/S0002-9440(10)63674-7

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference